We also found that the CNVs of DR3 and CIITA were higher in the high-GASC group, and the methylation level of THY1 was lower in the high-GASC group, which could be a potential treatment target for glioma, particularly in HGG. The gene discussed is TNFRSF25; the disease is glioma.